Contralateral risk-reducing mastectomy in young breast cancer patients with and without genetic cancer risk assessment.
about
Timing of risk reducing mastectomy in breast cancer patients carrying a BRCA1/2 mutation: retrospective data from the Dutch HEBON studyDevelopment and evaluation of a decision aid for BRCA carriers with breast cancerImpact that Timing of Genetic Mutation Diagnosis has on Surgical Decision Making and Outcome for BRCA1/BRCA2 Mutation Carriers with Breast Cancer.Clinical interpretation of pathogenic ATM and CHEK2 variants on multigene panel tests: navigating moderate risk.
P2860
Contralateral risk-reducing mastectomy in young breast cancer patients with and without genetic cancer risk assessment.
description
2008 nî lūn-bûn
@nan
2008 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Contralateral risk-reducing ma ...... enetic cancer risk assessment.
@ast
Contralateral risk-reducing ma ...... enetic cancer risk assessment.
@en
Contralateral risk-reducing ma ...... enetic cancer risk assessment.
@nl
type
label
Contralateral risk-reducing ma ...... enetic cancer risk assessment.
@ast
Contralateral risk-reducing ma ...... enetic cancer risk assessment.
@en
Contralateral risk-reducing ma ...... enetic cancer risk assessment.
@nl
prefLabel
Contralateral risk-reducing ma ...... enetic cancer risk assessment.
@ast
Contralateral risk-reducing ma ...... enetic cancer risk assessment.
@en
Contralateral risk-reducing ma ...... enetic cancer risk assessment.
@nl
P2093
P2860
P1476
Contralateral risk-reducing ma ...... enetic cancer risk assessment.
@en
P2093
Melanie R Palomares
Phuong L Mai
Veronica I Lagos
P2860
P2888
P304
P356
10.1245/S10434-008-0160-3
P577
2008-10-04T00:00:00Z
P5875
P6179
1034874015